Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AAPL Apple	$217.90 -2.7%	$230.70	$164.08 ▼ $260.10	$3.27T	1.18	54.85 million shs	39.78 million shs
AMGN Amgen	$306.95 +0.4%	$301.08	$253.30 ▼ $346.85	$164.90B	0.53	2.70 million shs	1.77 million shs
AMZN Amazon.com	$192.72 -4.3%	$216.86	$151.61 ▼ $242.52	$2.04T	1.19	39.83 million shs	52.45 million shs
AXP American Express	$265.16 -2.5%	$295.02	$214.51 ▼ $326.28	$186.28B	1.21	2.76 million shs	3.26 million shs
DIS Walt Disney	$98.02 -2.4%	$107.31	$83.91 ▼ $123.69	$177.19B	1.41	9.81 million shs	7.68 million shs
HZNP Horizon Therapeutics Public	$116.30	$115.72	$60.03 ▼ $116.38	$26.63B	1.03	2.50 million shs	N/A
NFLX Netflix	$933.85 -4.4%	$971.74	$542.01 ▼ $1,064.50	$399.46B	1.38	3.58 million shs	4.42 million shs

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AAPL Apple	+1.05%	+4.55%	-9.39%	-12.42%	+29.16%
AMGN Amgen	+0.02%	-2.94%	-3.12%	+16.42%	+6.80%
AMZN Amazon.com	+0.11%	+3.29%	-5.38%	-10.01%	+11.97%
AXP American Express	-1.39%	+0.50%	-7.15%	-9.60%	+19.47%
DIS Walt Disney	-0.20%	+1.68%	-9.15%	-9.95%	-16.97%
HZNP Horizon Therapeutics Public	0.00%	0.00%	0.00%	0.00%	0.00%
NFLX Netflix	+0.63%	+2.72%	-0.05%	+7.62%	+59.20%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AAPL Apple	4.6641 of 5 stars	3.3	4.0	3.3	2.8	2.1	1.7	1.9
AMGN Amgen	4.4359 of 5 stars	2.2	4.0	3.3	3.9	3.7	2.5	0.6
AMZN Amazon.com	4.9255 of 5 stars	4.5	3.0	1.7	3.0	3.3	3.3	1.9
AXP American Express	4.8272 of 5 stars	3.1	3.0	2.5	3.0	3.4	3.3	2.5
DIS Walt Disney	4.8624 of 5 stars	4.4	3.0	2.5	4.0	3.3	1.7	1.3
HZNP Horizon Therapeutics Public	1.1305 of 5 stars	0.0	0.0	0.0	3.2	0.6	1.7	1.9
NFLX Netflix	4.0433 of 5 stars	2.4	3.0	0.0	2.8	3.3	2.5	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AAPL Apple	2.60	Moderate Buy	$245.52	12.68% Upside
AMGN Amgen	2.48	Hold	$314.04	2.31% Upside
AMZN Amazon.com	2.98	Moderate Buy	$260.65	35.25% Upside
AXP American Express	2.27	Hold	$302.57	14.11% Upside
DIS Walt Disney	2.85	Moderate Buy	$125.64	28.18% Upside
HZNP Horizon Therapeutics Public	0.00	N/A	N/A	N/A
NFLX Netflix	2.78	Moderate Buy	$1,021.02	9.33% Upside

Current Analyst Ratings Breakdown

Latest AXP, AMGN, HZNP, AAPL, NFLX, AMZN, and DIS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/27/2025	NFLX Netflix	FBN Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$1,165.00
3/24/2025	NFLX Netflix	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
3/24/2025	AXP American Express	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$320.00 ➝ $300.00
3/18/2025	AAPL Apple	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$260.00 ➝ $275.00
3/18/2025	AXP American Express	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$367.00 ➝ $330.00
3/18/2025	AXP American Express	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$326.00 ➝ $325.00
3/17/2025	NFLX Netflix	Moffett Nathanson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$850.00 ➝ $1,100.00
3/14/2025	AAPL Apple	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$325.00 ➝ $325.00
3/14/2025	AXP American Express	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
3/14/2025	AXP American Express	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
3/14/2025	AXP American Express	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underperform ➝ Neutral	$265.00 ➝ $265.00

(Data available from 3/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AAPL Apple	$395.76B	8.27	$6.78 per share	32.16	$3.77 per share	57.80
AMGN Amgen	$33.42B	4.93	$30.76 per share	9.98	$10.93 per share	28.08
AMZN Amazon.com	$637.96B	3.20	$9.41 per share	20.49	$26.98 per share	7.14
AXP American Express	$65.95B	2.82	$14.44 per share	18.36	$42.96 per share	6.17
DIS Walt Disney	$92.50B	1.92	$8.65 per share	11.33	$59.04 per share	1.66
HZNP Horizon Therapeutics Public	$3.63B	7.34	$7.05 per share	16.49	$22.38 per share	5.20
NFLX Netflix	$39.00B	10.24	$51.88 per share	18.00	$57.85 per share	16.14

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AAPL Apple	$93.74B	$6.30	34.59	26.57	2.44	24.30%	160.83%	30.88%	5/1/2025 (Estimated)
AMGN Amgen	$4.09B	$7.55	40.66	14.35	2.63	12.24%	176.32%	11.71%	5/1/2025 (Estimated)
AMZN Amazon.com	$59.25B	$5.53	34.85	25.90	1.50	9.29%	24.25%	10.55%	4/29/2025 (Estimated)
AXP American Express	$10.13B	$14.01	18.93	15.07	1.41	15.36%	32.65%	3.56%	4/17/2025 (Estimated)
DIS Walt Disney	$4.97B	$3.07	31.93	15.99	1.80	6.07%	9.95%	5.33%	5/6/2025 (Estimated)
HZNP Horizon Therapeutics Public	$521.48M	$1.87	62.19	20.55	3.96	12.02%	20.46%	11.52%	N/A
NFLX Netflix	$8.71B	$19.83	47.09	31.52	2.12	22.34%	38.32%	17.09%	4/17/2025 (Estimated)

Latest AXP, AMGN, HZNP, AAPL, NFLX, AMZN, and DIS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/17/2025	N/A	AXP American Express	$3.47	N/A	N/A	N/A	$17.04 billion	N/A
4/17/2025	N/A	NFLX Netflix	$5.74	N/A	N/A	N/A	$10.51 billion	N/A
2/6/2025	Q4 2024	AMZN Amazon.com	$1.52	$1.86	+$0.34	$1.86	$187.25 billion	N/A
2/5/2025	Q1 2025	DIS Walt Disney	$1.44	$1.76	+$0.32	$1.40	$24.55 billion	N/A
2/4/2025	Q4 2024	AMGN Amgen	$5.04	$5.31	+$0.27	$1.16	$8.87 billion	N/A
1/30/2025	Q1 2025	AAPL Apple	$2.36	$2.40	+$0.04	$2.40	$124.04 billion	N/A
1/24/2025	Q4 2024	AXP American Express	$3.00	$3.04	+$0.04	$3.04	$17.17 billion	N/A
1/21/2025	Q4 2024	NFLX Netflix	$4.20	$4.27	+$0.07	$4.27	$10.14 billion	$10.25 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AAPL Apple	$1.00	0.46%	+4.60%	15.87%	13 Years
AMGN Amgen	$9.52	3.10%	+8.53%	126.09%	14 Years
AMZN Amazon.com	$0.20	0.10%	N/A	3.62%	N/A
AXP American Express	$3.28	1.24%	+17.64%	23.41%	N/A
DIS Walt Disney	$1.00	1.02%	N/A	32.57%	N/A
HZNP Horizon Therapeutics Public	N/A	N/A	N/A	N/A	N/A
NFLX Netflix	N/A	N/A	N/A	N/A	N/A

Latest AXP, AMGN, HZNP, AAPL, NFLX, AMZN, and DIS Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/4/2025	AMGN Amgen	quarterly	$2.38	3.05%	5/16/2025	5/16/2025	6/6/2025
3/3/2025	AXP American Express	quarterly	$0.82	1.11%	4/4/2025	4/4/2025	5/9/2025
1/30/2025	AAPL Apple	quarterly	$0.25	0.42%	2/10/2025	2/10/2025	2/13/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AAPL Apple	1.26	0.92	0.88
AMGN Amgen	9.62	1.26	0.95
AMZN Amazon.com	0.18	1.06	0.87
AXP American Express	1.64	1.58	1.57
DIS Walt Disney	0.36	0.68	0.62
HZNP Horizon Therapeutics Public	0.48	4.27	4.09
NFLX Netflix	0.56	1.22	1.22

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AAPL Apple	67.73%
AMGN Amgen	76.50%
AMZN Amazon.com	72.20%
AXP American Express	84.33%
DIS Walt Disney	65.71%
HZNP Horizon Therapeutics Public	80.37%
NFLX Netflix	80.93%

Insider Ownership

Company	Insider Ownership
AAPL Apple	0.06%
AMGN Amgen	0.69%
AMZN Amazon.com	10.80%
AXP American Express	0.12%
DIS Walt Disney	0.16%
HZNP Horizon Therapeutics Public	2.20%
NFLX Netflix	1.76%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AAPL Apple	164,000	15.02 billion	15.01 billion	Optionable
AMGN Amgen	28,000	537.21 million	533.50 million	Optionable
AMZN Amazon.com	1,541,000	10.60 billion	9.45 billion	Optionable
AXP American Express	77,300	702.53 million	701.76 million	Optionable
DIS Walt Disney	220,000	1.81 billion	1.80 billion	Optionable
HZNP Horizon Therapeutics Public	2,115	228.99 million	223.96 million	Optionable
NFLX Netflix	14,000	427.76 million	420.23 million	Optionable

AXP, AMGN, HZNP, AAPL, NFLX, AMZN, and DIS Headlines

Recent News About These Companies

Why Are Analysts Bullish on Netflix (NFLX) for 2025?

March 28 at 7:04 PM | msn.com

Netflix (NASDAQ:NFLX) Trading Down 1.3% After Insider Selling

March 28 at 5:52 PM | marketbeat.com

Why Digital Ad Giants Alphabet, Meta Platforms, and Netflix Plunged Today

March 28 at 3:28 PM | fool.com

Netflix (NASDAQ:NFLX) Shares Down 3% - What's Next?

March 28 at 2:56 PM | marketbeat.com

Netflix 'Wants the Super Bowl But Not an NFL Package'

March 28 at 11:06 AM | investopedia.com

No more Netflix or California wine: Why thousands of Danes are refusing to buy American

March 28 at 7:23 AM | cbc.ca

Gardner Lewis Asset Management L P Sells 432 Shares of Netflix, Inc. (NASDAQ:NFLX)

March 28 at 7:20 AM | marketbeat.com

Netflix, Inc. (NASDAQ:NFLX) Shares Sold by DnB Asset Management AS

March 28 at 7:18 AM | marketbeat.com

Alerus Financial NA Sells 436 Shares of Netflix, Inc. (NASDAQ:NFLX)

March 28 at 7:11 AM | marketbeat.com

Level Four Advisory Services LLC Purchases 592 Shares of Netflix, Inc. (NASDAQ:NFLX)

March 28 at 7:08 AM | marketbeat.com

denkapparat Operations GmbH Takes Position in Netflix, Inc. (NASDAQ:NFLX)

March 28 at 6:57 AM | marketbeat.com

Premier Fund Managers Ltd Invests $10.85 Million in Netflix, Inc. (NASDAQ:NFLX)

March 28 at 6:50 AM | marketbeat.com

Netflix, Inc. (NASDAQ:NFLX) Shares Sold by Orion Portfolio Solutions LLC

March 28 at 6:49 AM | marketbeat.com

Pictet Asset Management Holding SA Sells 60,167 Shares of Netflix, Inc. (NASDAQ:NFLX)

March 28 at 6:42 AM | marketbeat.com

Nomura Asset Management Co. Ltd. Trims Stake in Netflix, Inc. (NASDAQ:NFLX)

March 28 at 6:41 AM | marketbeat.com

Rattled by the Stock Market Sell-Off? These 3 Stocks Outperformed the S&P 500 During the Great Recession

March 28 at 6:30 AM | fool.com

Caisse Des Depots ET Consignations Buys New Stake in Netflix, Inc. (NASDAQ:NFLX)

March 28 at 5:56 AM | marketbeat.com

Sava Infond d.o.o. Purchases New Position in Netflix, Inc. (NASDAQ:NFLX)

March 28 at 5:30 AM | marketbeat.com

WINTON GROUP Ltd Invests $2.77 Million in Netflix, Inc. (NASDAQ:NFLX)

March 28 at 5:22 AM | marketbeat.com

This Technology Stock Might be a Spectacular Buy After the Nasdaq Correction, According to Wall Street Analysts

March 28 at 4:27 AM | fool.com

Analysts Set Netflix, Inc. (NASDAQ:NFLX) Price Target at $1,016.78

March 28 at 3:17 AM | americanbankingnews.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
By Ryan Hasson | March 3, 2025
View 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
Everything About Amazon Stock Signals a Buy—Time to Load Up?
By Sam Quirke | March 20, 2025
View Everything About Amazon Stock Signals a Buy—Time to Load Up?
Institutions Bought 3 Stocks Heavily in Q1 2025
By Thomas Hughes | March 12, 2025
View Institutions Bought 3 Stocks Heavily in Q1 2025
3 Hot Stock Upgrades as Analysts Look Ahead to Q2 Earnings
By Thomas Hughes | March 19, 2025
View 3 Hot Stock Upgrades as Analysts Look Ahead to Q2 Earnings
CarMax and Carvana: Steering the Used Car Market
By Jeffrey Neal Johnson | March 27, 2025
View CarMax and Carvana: Steering the Used Car Market

AXP, AMGN, HZNP, AAPL, NFLX, AMZN, and DIS Company Descriptions

Apple NASDAQ:AAPL

$217.90 -5.95 (-2.66%)

Closing price 04:00 PM Eastern

Extended Trading

$217.31 -0.59 (-0.27%)

As of 08:00 PM Eastern

Apple Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide. The company offers iPhone, a line of smartphones; Mac, a line of personal computers; iPad, a line of multi-purpose tablets; and wearables, home, and accessories comprising AirPods, Apple TV, Apple Watch, Beats products, and HomePod. It also provides AppleCare support and cloud services; and operates various platforms, including the App Store that allow customers to discover and download applications and digital content, such as books, music, video, games, and podcasts. In addition, the company offers various services, such as Apple Arcade, a game subscription service; Apple Fitness+, a personalized fitness service; Apple Music, which offers users a curated listening experience with on-demand radio stations; Apple News+, a subscription news and magazine service; Apple TV+, which offers exclusive original content; Apple Card, a co-branded credit card; and Apple Pay, a cashless payment service, as well as licenses its intellectual property. The company serves consumers, and small and mid-sized businesses; and the education, enterprise, and government markets. It distributes third-party applications for its products through the App Store. The company also sells its products through its retail and online stores, and direct sales force; and third-party cellular network carriers, wholesalers, retailers, and resellers. Apple Inc. was founded in 1976 and is headquartered in Cupertino, California.

Amgen NASDAQ:AMGN

$306.95 +1.18 (+0.39%)

Closing price 04:00 PM Eastern

Extended Trading

$304.02 -2.94 (-0.96%)

As of 07:54 PM Eastern

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Amazon.com NASDAQ:AMZN

$192.72 -8.64 (-4.29%)

Closing price 04:00 PM Eastern

Extended Trading

$192.67 -0.05 (-0.03%)

As of 08:00 PM Eastern

Amazon.com, Inc. engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). It also manufactures and sells electronic devices, including Kindle, Fire tablets, Fire TVs, Echo, Ring, Blink, and eero; and develops and produces media content. In addition, the company offers programs that enable sellers to sell their products in its stores; and programs that allow authors, independent publishers, musicians, filmmakers, Twitch streamers, skill and app developers, and others to publish and sell content. Further, it provides compute, storage, database, analytics, machine learning, and other services, as well as advertising services through programs, such as sponsored ads, display, and video advertising. Additionally, the company offers Amazon Prime, a membership program. The company's products offered through its stores include merchandise and content purchased for resale and products offered by third-party sellers. It serves consumers, sellers, developers, enterprises, content creators, advertisers, and employees. Amazon.com, Inc. was incorporated in 1994 and is headquartered in Seattle, Washington.

American Express NYSE:AXP

$265.16 -6.86 (-2.52%)

Closing price 03:59 PM Eastern

Extended Trading

$264.00 -1.15 (-0.43%)

As of 07:59 PM Eastern

American Express Company, together with its subsidiaries, operates as integrated payments company in the United States, Europe, the Middle East and Africa, the Asia Pacific, Australia, New Zealand, Latin America, Canada, the Caribbean, and Internationally. It operates through four segments: U.S. Consumer Services, Commercial Services, International Card Services, and Global Merchant and Network Services. The company's products and services include credit card, charge card, banking, and other payment and financing products; network services; expense management products and services; and travel and lifestyle services. It also provides merchant acquisition and processing, servicing and settlement, point-of-sale marketing, and information products and services for merchants; and fraud prevention services, as well as the design and operation of customer loyalty programs. In addition, the company operates lounges at airports under Centurion Lounge brand name. It sells its products and services to consumers, small businesses, mid-sized companies, and large corporations through mobile and online applications, affiliate marketing, customer referral programs, third-party service providers and business partners, direct mail, telephone, in-house sales teams, and direct response advertising. American Express Company was founded in 1850 and is headquartered in New York, New York.

Walt Disney NYSE:DIS

$98.02 -2.43 (-2.42%)

Closing price 03:59 PM Eastern

Extended Trading

$97.89 -0.13 (-0.13%)

As of 07:59 PM Eastern

The Walt Disney Company operates as an entertainment company worldwide. It operates through three segments: Entertainment, Sports, and Experiences. The company produces and distributes film and television video streaming content under the ABC Television Network, Disney, Freeform, FX, Fox, National Geographic, and Star brand television channels, as well as ABC television stations and A+E television networks; and produces original content under the ABC Signature, Disney Branded Television, FX Productions, Lucasfilm, Marvel, National Geographic Studios, Pixar, Searchlight Pictures, Twentieth Century Studios, 20th Television, and Walt Disney Pictures banners. It also offers direct-to-consumer streaming services through Disney+, Disney+ Hotstar, Hulu, and Star+; sports-related entertainment services through ESPN, ESPN on ABC, ESPN+ DTC, and Star; sale/licensing of film and episodic content to third-party television and VOD services; theatrical, home entertainment, and music distribution services; DVD and Blu-ray discs, electronic home video licenses, and VOD rental services; staging and licensing of live entertainment events; and post-production services. In addition, the company operates theme parks and resorts comprising Walt Disney World Resort, Disneyland Resort, Disneyland Paris, Hong Kong Disneyland Resort, Shanghai Disney Resort, Disney Cruise Line, Disney Vacation Club, National Geographic Expeditions, and Adventures by Disney, as well as Aulani, a Disney resort and spa in Hawaii. It also licenses its intellectual property to a third party for operations of the Tokyo Disney Resort; licenses trade names, characters, visual, literary, and other IP for use on merchandise, published materials, and games; operates a direct-to-home satellite distribution platform; sells branded merchandise through retail, online, and wholesale businesses; and develops and publishes books, comic books, and magazines. The company was founded in 1923 and is based in Burbank, California.

Horizon Therapeutics Public NASDAQ:HZNP

Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; Arrowhead Pharmaceuticals, Inc.; Q32 Bio Inc.; and Xeris Biopharma Holdings, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.

Netflix NASDAQ:NFLX

$933.85 -42.87 (-4.39%)

Closing price 04:00 PM Eastern

Extended Trading

$931.85 -2.00 (-0.21%)

As of 07:59 PM Eastern

Netflix, Inc. provides entertainment services. It offers TV series, documentaries, feature films, and games across various genres and languages. The company also provides members the ability to receive streaming content through a host of internet-connected devices, including TVs, digital video players, TV set-top boxes, and mobile devices. It has operations in approximately 190 countries. The company was incorporated in 1997 and is headquartered in Los Gatos, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AXP, AMGN, HZNP, AAPL, NFLX, AMZN, and DIS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AXP, AMGN, HZNP, AAPL, NFLX, AMZN, and DIS Earnings

Compare Dividends

Latest AXP, AMGN, HZNP, AAPL, NFLX, AMZN, and DIS Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AXP, AMGN, HZNP, AAPL, NFLX, AMZN, and DIS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

AXP, AMGN, HZNP, AAPL, NFLX, AMZN, and DIS Company Descriptions

Apple NASDAQ:AAPL

Amgen NASDAQ:AMGN

Amazon.com NASDAQ:AMZN

American Express NYSE:AXP

Walt Disney NYSE:DIS

Horizon Therapeutics Public NASDAQ:HZNP

Netflix NASDAQ:NFLX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools